Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Nail Toxicities with FGFR Inhibitors — A JDD Systematic Review Worth Reading Have you read this article from the March 2026 issue of JDD? A systematic review covering reports through…
Dermatology Times highlighted three Journal of Drugs in Dermatology studies in recent articles, including an examination of “fungal acne.” In the study, “Malassezia Folliculitis Presentation, Diagnosis, and Treatment: A Review…
Beyond the Face: New JDD Data on Décolletage Rejuvenation With PLLA-SCA Have you read this article from the JDD? A new study is drawing attention to an area that aesthetic patients are…
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Bacteriophages in Acne Care: A New JDD Study to Watch This is a must-read article from JDD for dermatology professionals following the search for new acne treatments. A randomized, double-blind,…
New Review Highlights How Dermatologists May Better Identify cSCC Patients Who Benefit From Adjuvant Radiation Have you read this article from the JDD? A new systematic review is drawing attention to…